Abbott integrates CGM into Tandem's automated insulin pump
Abbott (NYSEABT) and Tandem Diabetes Care (Nasdaq:TNDM) announced the integration of FreeStyle Libre 2 CGM into the t:slim X2 insulin pump.
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems - Mar 6, 2023
Insulin Delivery Device Technology — Today and Into the Future - Today's Dietitian Magazine
Tandem Diabetes Care Launches Insulin Pump With Dexcom G5 Mobile CGM Integration
Manuel Hernández على LinkedIn: Environmental Protection Specialist
Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US
Barriers to uptake of insulin technologies
Drug Delivery Business News on LinkedIn: Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI…
Erica Scott - CSAM on LinkedIn: Vertex cuts ties to CRISPR Therapeutics' type 1 diabetes stem cell therapy
Abbott and Tandem integrate insulin devices - HealthTekPak
Tandem — Healthy Living Blog — Healthy Living Medical Supply
Diabetes Care Technology Coming In 2023
Ahmed Sasi on LinkedIn: Exploring the Therapeutic Potential of Once Weekly Basal Insulin Therapy
Continuous Glucose Monitoring (CGM): What It Is and Who Can Benefit